AtriCure (ATRC) News Today $33.62 -1.23 (-3.53%) Closing price 04:00 PM EasternExtended Trading$34.33 +0.71 (+2.11%) As of 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period AtriCure Highlights Growth and Innovation at Investor DayMarch 26 at 1:51 PM | tipranks.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Emerald Advisers LLCEmerald Advisers LLC cut its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 77.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 89,098 shares of the medical device company's stock after selling 300,738 shares during theMarch 25 at 5:37 AM | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Given Average Rating of "Buy" by BrokeragesAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) has received an average recommendation of "Buy" from the nine analysts that are presently covering the company, Marketbeat reports. Nine equities research analysts have rated the stock with a buy rating. The average 1-year price objective among analysMarch 25 at 2:09 AM | marketbeat.comRoyce & Associates LP Has $748,000 Stake in AtriCure, Inc. (NASDAQ:ATRC)Royce & Associates LP decreased its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 62.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,482 shares of the medical device company'sMarch 23 at 4:01 AM | marketbeat.comAtriCure's (ATRC) Buy Rating Reiterated at Needham & Company LLCMarch 23 at 1:33 AM | americanbankingnews.comAtriCure (NASDAQ:ATRC) Earns "Buy" Rating from Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and issued a $51.00 target price on shares of AtriCure in a research note on Friday.March 22, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by AmundiAmundi lowered its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 10.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 270,455 shares of the medical device company's stock after selling 31,3March 15, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Share Price Passes Above Two Hundred Day Moving Average - What's Next?AtriCure (NASDAQ:ATRC) Shares Pass Above 200-Day Moving Average - Should You Sell?March 15, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Shares Down 6% After Insider SellingAtriCure (NASDAQ:ATRC) Trading Down 6% Following Insider SellingMarch 8, 2025 | marketbeat.comKaren Prange Sells 6,100 Shares of AtriCure, Inc. (NASDAQ:ATRC) StockAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) Director Karen Prange sold 6,100 shares of the company's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $38.12, for a total value of $232,532.00. Following the transaction, the director now directly owns 17,828 shares in the company, valued at approximately $679,603.36. This trade represents a 25.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.March 8, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Director Karen Prange Sells 6,100 SharesMarch 8, 2025 | insidertrades.comInsider Sell: Karen Prange Sells 6,100 Shares of AtriCure Inc (ATRC)March 7, 2025 | gurufocus.comVersor Investments LP Acquires Shares of 7,100 AtriCure, Inc. (NASDAQ:ATRC)Versor Investments LP bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 7,100 shares of the medical device company's stock, valued at approximately $217,000. SevMarch 5, 2025 | marketbeat.comY Intercept Hong Kong Ltd Decreases Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)Y Intercept Hong Kong Ltd cut its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 31.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,997 shares of the medical device company's stock after selling 6,887 shares duMarch 3, 2025 | marketbeat.comRhumbline Advisers Has $2.41 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC)Rhumbline Advisers boosted its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 11.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 78,815 shares of the medical device company's stock after buyiMarch 3, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Buy" from BrokeragesShares of AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) have received an average recommendation of "Buy" from the nine research firms that are currently covering the company, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average twFebruary 28, 2025 | marketbeat.comCowa LLC Acquires Shares of 7,097 AtriCure, Inc. (NASDAQ:ATRC)Cowa LLC acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 7,097 shares of the medical device company's stock, valued at approximately $217,000. A number of other institutionalFebruary 23, 2025 | marketbeat.comHighMark Wealth Management LLC Buys 13,500 Shares of AtriCure, Inc. (NASDAQ:ATRC)HighMark Wealth Management LLC lifted its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 19.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 83,725 shares of the medical device company's stockFebruary 18, 2025 | marketbeat.comAlphaCentric Advisors LLC Makes New Investment in AtriCure, Inc. (NASDAQ:ATRC)AlphaCentric Advisors LLC bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 26,035 shares of the medical device company's stock, valued at approximately $796,000. AlphaFebruary 17, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Sees Significant Decrease in Short InterestAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the target of a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 1,170,000 shares, a decrease of 20.4% from the January 15th total of 1,470,000 shares. Based on an average trading volume of 480,400 shares, the short-interest ratio is presently 2.4 days.February 16, 2025 | marketbeat.comAtriCure Full Year 2024 Earnings: EPS Misses ExpectationsFebruary 14, 2025 | finance.yahoo.comAtriCure files automatic mixed securities shelfFebruary 14, 2025 | markets.businessinsider.comAtriCure, Inc. (NASDAQ:ATRC) Q4 2024 Earnings Call TranscriptFebruary 14, 2025 | msn.comHood River Capital Management LLC Increases Stake in AtriCure IncFebruary 14, 2025 | gurufocus.comAtriCure price target raised to $57 from $53 at BTIGFebruary 14, 2025 | markets.businessinsider.comAtriCure targets $517M-$527M revenue in 2025 with new product launches and international growthFebruary 13, 2025 | msn.comAtriCure price target raised to $66 from $61 at CanaccordFebruary 13, 2025 | markets.businessinsider.comAtriCure (NASDAQ:ATRC) Shares Down 5.8% - What's Next?AtriCure (NASDAQ:ATRC) Shares Down 5.8% - Here's What HappenedFebruary 13, 2025 | marketbeat.comOppenheimer Issues Positive Forecast for AtriCure (NASDAQ:ATRC) Stock PriceOppenheimer upped their price target on shares of AtriCure from $36.00 to $45.00 and gave the stock an "outperform" rating in a research report on Thursday.February 13, 2025 | marketbeat.comPiper Sandler Forecasts Strong Price Appreciation for AtriCure (NASDAQ:ATRC) StockPiper Sandler upped their price target on AtriCure from $40.00 to $50.00 and gave the stock an "overweight" rating in a report on Thursday.February 13, 2025 | marketbeat.comStifel Nicolaus Forecasts Strong Price Appreciation for AtriCure (NASDAQ:ATRC) StockStifel Nicolaus lifted their price objective on shares of AtriCure from $36.00 to $48.00 and gave the stock a "buy" rating in a research report on Thursday.February 13, 2025 | marketbeat.comAtriCure's (ATRC) Buy Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $51.00 target price on shares of AtriCure in a research note on Thursday.February 13, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Canaccord Genuity Group Analyst SaysCanaccord Genuity Group raised their price objective on AtriCure from $61.00 to $66.00 and gave the stock a "buy" rating in a research note on Thursday.February 13, 2025 | marketbeat.comAtriCure Inc (ATRC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...February 13, 2025 | gurufocus.comAtriCure (ATRC) to Release Earnings on ThursdayAtriCure (NASDAQ:ATRC) will be releasing earnings after the market closes on Thursday, February 20, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=658222)February 13, 2025 | marketbeat.comQ4 2024 AtriCure Inc Earnings Call TranscriptFebruary 13, 2025 | gurufocus.comAtriCure, Inc. (ATRC) Q4 2024 Earnings Call TranscriptFebruary 12, 2025 | seekingalpha.comAtriCure sees FY25 EPS (64c) to (57c), consensus (60c)February 12, 2025 | markets.businessinsider.comAtriCure reports Q4 EPS (8c), consensus (15c)February 12, 2025 | markets.businessinsider.comAtriCure (NASDAQ:ATRC) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPSAtriCure (NASDAQ:ATRC - Get Free Report) posted its quarterly earnings data on Wednesday. The medical device company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $0.07. AtriCure had a negative net margin of 8.70% and a negative return on equity of 8.12%.February 12, 2025 | marketbeat.comAtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial ResultsFebruary 12, 2025 | businesswire.comAtriCure price target raised to $51 from $40 at JPMorganFebruary 12, 2025 | markets.businessinsider.comAtriCure (NASDAQ:ATRC) Price Target Raised to $51.00JPMorgan Chase & Co. increased their price objective on shares of AtriCure from $40.00 to $51.00 and gave the company an "overweight" rating in a research report on Tuesday.February 11, 2025 | marketbeat.comJMP Securities Reaffirms "Market Outperform" Rating for AtriCure (NASDAQ:ATRC)JMP Securities restated a "market outperform" rating and set a $60.00 target price on shares of AtriCure in a research report on Monday.February 10, 2025 | marketbeat.comJMP reiterates AtriCure stock with $60 target, sees growthFebruary 10, 2025 | msn.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by WCM Investment Management LLCWCM Investment Management LLC trimmed its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 11.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 191,801 shares of the medical device company's sFebruary 10, 2025 | marketbeat.comJMP Securities Reaffirms Their Buy Rating on Atricure (ATRC)February 10, 2025 | markets.businessinsider.comJMP Securities Reaffirms Their Buy Rating on Atricure (ATRC)February 10, 2025 | markets.businessinsider.comSilver Oak Securities Incorporated Purchases Shares of 7,278 AtriCure, Inc. (NASDAQ:ATRC)Silver Oak Securities Incorporated bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 7,278 shares of the medical device company's stock, valued at approxFebruary 10, 2025 | marketbeat.comCalamos Advisors LLC Boosts Holdings in AtriCure, Inc. (NASDAQ:ATRC)Calamos Advisors LLC increased its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 27.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 110,671 shares of the medical device company's stock after purchasing an additional 24,14February 5, 2025 | marketbeat.com Remove Ads Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address ATRC Media Mentions By Week ATRC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATRC News Sentiment▼0.980.89▲Average Medical News Sentiment ATRC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATRC Articles This Week▼84▲ATRC Articles Average Week Remove Ads Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TFX News Today ITGR News Today IART News Today ATEC News Today OFIX News Today SRDX News Today ANGO News Today ARAY News Today RMTI News Today RSLS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATRC) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATRC Stock Free ATRC Stock Alerts